Literature DB >> 10998565

Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.

R A Crowther1, S E Daniel, M Goedert.   

Abstract

The defining neuropathological deposits of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are strongly immunoreactive for alpha-synuclein. We have shown previously that isolated filaments from dementia with Lewy bodies and multiple system atrophy brains are labelled in a characteristic fashion by a number of alpha-synuclein antibodies. Here we have extracted filaments from substantia nigra of patients with idiopathic Parkinson's disease. Antibodies directed against the carboxy-terminal region of alpha-synuclein labelled isolated filaments along their entire lengths. By contrast, an antibody directed against the amino-terminal region of alpha-synuclein only labelled one filament end. These characteristics were identical to those of filaments extracted from brains of patients with dementia with Lewy bodies and multiple system atrophy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998565     DOI: 10.1016/s0304-3940(00)01440-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  59 in total

1.  The protofilament structure of insulin amyloid fibrils.

Authors:  José L Jiménez; Ewan J Nettleton; Mario Bouchard; Carol V Robinson; Christopher M Dobson; Helen R Saibil
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

2.  Polycation-induced oligomerization and accelerated fibrillation of human alpha-synuclein in vitro.

Authors:  John Goers; Vladimir N Uversky; Anthony L Fink
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

3.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

Review 4.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

5.  Structured regions of α-synuclein fibrils include the early-onset Parkinson's disease mutation sites.

Authors:  Gemma Comellas; Luisel R Lemkau; Andrew J Nieuwkoop; Kathryn D Kloepper; Daniel T Ladror; Reika Ebisu; Wendy S Woods; Andrew S Lipton; Julia M George; Chad M Rienstra
Journal:  J Mol Biol       Date:  2011-06-21       Impact factor: 5.469

Review 6.  Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs).

Authors:  Francois-Xavier Theillet; Andres Binolfi; Tamara Frembgen-Kesner; Karan Hingorani; Mohona Sarkar; Ciara Kyne; Conggang Li; Peter B Crowley; Lila Gierasch; Gary J Pielak; Adrian H Elcock; Anne Gershenson; Philipp Selenko
Journal:  Chem Rev       Date:  2014-06-05       Impact factor: 60.622

7.  Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.

Authors:  Jinxia Lu; Shengnan Zhang; Xiaojuan Ma; Chunyu Jia; Zhenying Liu; Chengan Huang; Cong Liu; Dan Li
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

Review 8.  Parkinson's disease and parkinsonism: neuropathology.

Authors:  Dennis W Dickson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.

Authors:  Christophe Lo Bianco; James Shorter; Etienne Régulier; Hilal Lashuel; Takeshi Iwatsubo; Susan Lindquist; Patrick Aebischer
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

10.  Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease.

Authors:  James B Koprich; Tom H Johnston; M Gabriela Reyes; Xuan Sun; Jonathan M Brotchie
Journal:  Mol Neurodegener       Date:  2010-10-28       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.